Paper6327770
Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
Waldmann TA and 9 others. J Clin Invest, 1984. Cited by 219 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor. Papers, record 6327770. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/6327770
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Functional and phenotypic comparison of human T cell leukemia/lymphoma virus positive adult T cell leukemia with human T cell leukemia/lymphoma virus negative Sézary leukemia, and their distinction using anti-Tac. Monoclonal antibody identifying the human receptor for T cell growth factor.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Deltaretrovirus | Major topic |
| Leukemia | Major topic |
| Lymphoma | Major topic |
| Receptors, Immunologic | Major topic |
| Retroviridae | Major topic |
| Sezary Syndrome | Major topic |
| T-Lymphocytes | Major topic |
| Adult | |
| Antibodies, Monoclonal | |
| Antibody Formation | |
| Humans | |
| Phenotype | |
| Receptors, Interleukin-2 | |
| Reference Values |
Source PubMed
Trials1
The trials whose ClinicalTrials.gov record lists the paper, and the trial numbers the paper's PubMed record names.
| Trial | Title | The trial lists it as | Named in the paper's record |
|---|---|---|---|
| NCT00924170 | Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia | Background |
Source ClinicalTrials.gov
References41
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 181,845 | Selective in vitro growth of T lymphocytes from normal human bone marrows. | Science | 1976 | https://conductscience.org/library/papers/181845 | PubMed |
| 2 | 6,982,476 | Human T-cell leukemia-lymphoma virus (HTLV) is in T but not B lymphocytes from a patient with cutaneous T-cell lymphoma. | Proc Natl Acad Sci U S A | 1982 | https://conductscience.org/library/papers/6982476 | PubMed |
| 3 | 6,815,536 | A monoclonal antibody that appears to recognize the receptor for human T-cell growth factor; partial characterization of the receptor. | Nature | 1982 | https://conductscience.org/library/papers/6815536 | PubMed |
| 4 | 6,293,176 | Identification of HTLV p19 specific natural human antibodies by competition with monoclonal antibody. | Virology | 1982 | https://conductscience.org/library/papers/6293176 | PubMed |
| 5 | 6,984,061 | Possible involvement of the OKT4 molecule in T cell recognition of class II HLA antigens. Evidence from studies of cytotoxic T lymphocytes specific for SB antigens. | J Exp Med | 1982 | https://conductscience.org/library/papers/6984061 | PubMed |
| 6 | 6,600,519 | Isolation and transmission of human retrovirus (human t-cell leukemia virus). | Science | 1983 | https://conductscience.org/library/papers/6600519 | PubMed |
| 7 | 6,300,254 | Epidemiology of human T-cell leukemia/lymphoma virus. | J Infect Dis | 1983 | https://conductscience.org/library/papers/6300254 | PubMed |
| 8 | 6,308,290 | The human T-cell leukemia-lymphoma virus in the southeastern United States. | JAMA | 1983 | https://conductscience.org/library/papers/6308290 | PubMed |
| 9 | 6,195,529 | Association of human T-cell leukaemia/lymphoma virus with the Tac antigen marker for the human T-cell growth factor receptor. | Nature | 1983 | https://conductscience.org/library/papers/6195529 | PubMed |
| 10 | 6,417,659 | Characterization of the human receptor for T-cell growth factor. | Proc Natl Acad Sci U S A | 1983 | https://conductscience.org/library/papers/6417659 | PubMed |
| 11 | 6,764,996 | Progress in adult T cell leukemia research. | Acta Pathol Jpn | 1982 | https://conductscience.org/library/papers/6764996 | PubMed |
| 12 | 794,413 | The T cell dependence of B cell differentiation induced by pokeweed mitogen. | J Immunol | 1976 | https://conductscience.org/library/papers/794413 | PubMed |
| 13 | 301,762 | Adult T-cell leukemia: clinical and hematologic features of 16 cases. | Blood | 1977 | https://conductscience.org/library/papers/301762 | PubMed |
| 14 | 304,175 | Characterization of a suppressor-cell leukemia. Evidence for the requirement of an interaction of two T cells in the development of human suppressor effector cells. | N Engl J Med | 1978 | https://conductscience.org/library/papers/304175 | PubMed |
| 15 | 306,907 | Effect of adult T-cell leukemia cells on pokeweed mitogen-induced normal B-cell differentiation. | Clin Immunol Immunopathol | 1978 | https://conductscience.org/library/papers/306907 | PubMed |
| 16 | 101,844 | The suppressor-cell network in cancer (first of two parts). | N Engl J Med | 1978 | https://conductscience.org/library/papers/101844 | PubMed |
| 17 | 310,966 | An Lyt differentiated thymocyte subpopulation detected by flow microfluorometry. | Nature | 1979 | https://conductscience.org/library/papers/310966 | PubMed |
| 18 | 311,642 | Cutaneous T-cell lymphoma: neoplasm of T cells with helper activity. | Blood | 1979 | https://conductscience.org/library/papers/311642 | PubMed |
| 19 | 313,290 | Suppressor cell population in Sézary syndrome. | Clin Immunol Immunopathol | 1979 | https://conductscience.org/library/papers/313290 | PubMed |
| 20 | 315,070 | Separation of functional subsets of human T cells by a monoclonal antibody. | Proc Natl Acad Sci U S A | 1979 | https://conductscience.org/library/papers/315070 | PubMed |
Cited by35
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 219 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40,680,114 | BLIMP1 negatively regulates IL-2 signaling in T cells. | Sci Adv | 2025 | https://conductscience.org/library/papers/40680114 | PubMed |
| 32,547,515 | Novel Treatments of Adult T Cell Leukemia Lymphoma. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32547515 | PubMed |
| 32,275,165 | 90Y-Daclizumab (Anti-CD25), High-Dose Carmustine, Etoposide, Cytarabine, and Melphalan Chemotherapy and Autologous Hematopoietic Stem Cell Transplant Yielded Sustained Complete Remissions in 4 Patients with Recurrent Hodgkin's Lymphoma. | Cancer Biother Radiopharm | 2020 | https://conductscience.org/library/papers/32275165 | PubMed |
| 28,087,047 | Rational design of low immunogenic anti CD25 recombinant immunotoxin for T cell malignancies by elimination of T cell epitopes in PE38. | Cell Immunol | 2017 | https://conductscience.org/library/papers/28087047 | PubMed |
| 26,438,866 | 90Y-daclizumab, an anti-CD25 monoclonal antibody, provided responses in 50% of patients with relapsed Hodgkin's lymphoma. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26438866 | PubMed |
| 26,350,263 | Complete Remissions of Adult T-cell Leukemia with Anti-CD25 Recombinant Immunotoxin LMB-2 and Chemotherapy to Block Immunogenicity. | Clin Cancer Res | 2016 | https://conductscience.org/library/papers/26350263 | PubMed |
| 25,733,162 | Dose-intensified chemotherapy alone or in combination with mogamulizumab in newly diagnosed aggressive adult T-cell leukaemia-lymphoma: a randomized phase II study. | Br J Haematol | 2015 | https://conductscience.org/library/papers/25733162 | PubMed |
| 25,267,440 | Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma. | Clin Immunol | 2014 | https://conductscience.org/library/papers/25267440 | PubMed |
| 23,352,221 | Interleukin-2 at the crossroads of effector responses, tolerance, and immunotherapy. | Immunity | 2013 | https://conductscience.org/library/papers/23352221 | PubMed |
| 21,993,874 | Antibody therapy for Adult T-cell leukemia-lymphoma. | Int J Hematol | 2011 | https://conductscience.org/library/papers/21993874 | PubMed |
| 21,951,590 | An IκB kinase 2 inhibitor IMD-0354 suppresses the survival of adult T-cell leukemia cells. | Cancer Sci | 2012 | https://conductscience.org/library/papers/21951590 | PubMed |
| 18,948,574 | Effective treatment of a murine model of adult T-cell leukemia using depsipeptide and its combination with unmodified daclizumab directed toward CD25. | Blood | 2009 | https://conductscience.org/library/papers/18948574 | PubMed |
| 18,569,641 | Expression of T-plastin, FoxP3 and other tumor-associated markers by leukemic T-cells of cutaneous T-cell lymphoma. | Leuk Lymphoma | 2008 | https://conductscience.org/library/papers/18569641 | PubMed |
| 18,475,497 | Biological significance of soluble IL-2 receptor. | Mediators Inflamm | 1993 | https://conductscience.org/library/papers/18475497 | PubMed |
| 16,569,769 | Effective treatment of a murine model of adult T-cell leukemia using 211At-7G7/B6 and its combination with unmodified anti-Tac (daclizumab) directed toward CD25. | Blood | 2006 | https://conductscience.org/library/papers/16569769 | PubMed |
| 12,692,230 | Rapid tumor formation of human T-cell leukemia virus type 1-infected cell lines in novel NOD-SCID/gammac(null) mice: suppression by an inhibitor against NF-kappaB. | J Virol | 2003 | https://conductscience.org/library/papers/12692230 | PubMed |
| 11,053,100 | Advances in interleukin 2 receptor targeted treatment. | Ann Rheum Dis | 2000 | https://conductscience.org/library/papers/11053100 | PubMed |
| 9,624,582 | Interleukin-1 alpha increases the preferential cytotoxicity of an interleukin-2-diphtheria toxin fusion protein against neoplastic lymphocytes from patients with the Sezary syndrome compared to normal lymphocytes. | J Clin Immunol | 1998 | https://conductscience.org/library/papers/9624582 | PubMed |
| 8,197,160 | A lymphokine, provisionally designated interleukin T and produced by a human adult T-cell leukemia line, stimulates T-cell proliferation and the induction of lymphokine-activated killer cells. | Proc Natl Acad Sci U S A | 1994 | https://conductscience.org/library/papers/8197160 | PubMed |
| 7,860,737 | The cutaneous T cell lymphoma, mycosis fungoides, is a human T cell lymphotropic virus-associated disease. A study of 50 patients. | J Clin Invest | 1995 | https://conductscience.org/library/papers/7860737 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| IL2 | 3,558 | PubTator's text mining | https://conductscience.org/library/genes/3558 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/6327770
GET https://conductscience.org/api/papers/v1/6327770/references?page=2